Charles Schwab’s Fennec Pharmaceuticals FENC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $509K | Buy |
61,287
+141
| +0.2% | +$1.17K | ﹤0.01% | 3134 |
|
|
2025
Q1 | $372K | Hold |
61,146
| – | – | ﹤0.01% | 3158 |
|
|
2024
Q4 | $386K | Buy |
61,146
+5,694
| +10% | +$36K | ﹤0.01% | 3212 |
|
|
2024
Q3 | $277K | Hold |
55,452
| – | – | ﹤0.01% | 3300 |
|
|
2024
Q2 | $339K | Buy |
55,452
+13,955
| +34% | +$85.3K | ﹤0.01% | 3334 |
|
|
2024
Q1 | $461K | Hold |
41,497
| – | – | ﹤0.01% | 3058 |
|
|
2023
Q4 | $466K | Hold |
41,497
| – | – | ﹤0.01% | 3093 |
|
|
2023
Q3 | $312K | Hold |
41,497
| – | – | ﹤0.01% | 3204 |
|
|
2023
Q2 | $366K | Buy |
+41,497
| New | +$366K | ﹤0.01% | 3177 |
|
|
2021
Q2 | – | Sell |
-45,870
| Closed | -$285K | – | 3458 |
|
|
2021
Q1 | $285K | Hold |
45,870
| – | – | ﹤0.01% | 3257 |
|
|
2020
Q4 | $342K | Buy |
45,870
+2,880
| +7% | +$21.5K | ﹤0.01% | 3109 |
|
|
2020
Q3 | $261K | Sell |
42,990
-3,594
| -8% | -$21.8K | ﹤0.01% | 3085 |
|
|
2020
Q2 | $389K | Buy |
+46,584
| New | +$389K | ﹤0.01% | 2930 |
|
|
2019
Q2 | – | Sell |
-27,211
| Closed | -$132K | – | 3234 |
|
|
2019
Q1 | $132K | Buy |
27,211
+6,111
| +29% | +$29.6K | ﹤0.01% | 3074 |
|
|
2018
Q4 | $135K | Hold |
21,100
| – | – | ﹤0.01% | 3066 |
|
|
2018
Q3 | $174K | Hold |
21,100
| – | – | ﹤0.01% | 3088 |
|
|
2018
Q2 | $221K | Buy |
+21,100
| New | +$221K | ﹤0.01% | 3050 |
|